CLINICAL_TRIALS
ClinicalTrials.gov record update
A Phase 3, 22-week, Multi-center, Randomized Withdrawal Study of TD-9855 in Treating Symptomatic Neurogenic Orthostatic Hypotension in Subjects With Primary Autonomic Failure
This page presents selected fields from the linked source record. It does not add a medical interpretation.
Record identity and dates
- Source
- ClinicalTrials.gov
- Source record ID
- NCT03829657
- Title field or adapter rule
- protocolSection.identificationModule.officialTitle
- Ingested At
- 2026-04-28T10:38:50.046121+00:00
- Published At
- 2023-01-20T00:00:00+00:00
- Record Updated At
- 2023-01-20
- Results Posted At
- 2023-01-20
- Timestamp Basis
- source retrieval time was not retained by the feed adapter
- Date limitation
- source retrieval time was not retained by the feed adapter
Fields recorded by this source
- protocolSection.conditionsModule.conditions
["Symptomatic Neurogenic Orthostatic Hypotension", "MSA", "Parkinson\u0027s Disease (PD)", "Pure Autonomic Failure (PAF)"]- protocolSection.statusModule.lastUpdatePostDateStruct.date
"2023-01-20"- protocolSection.identificationModule.nctId
"NCT03829657"- protocolSection.identificationModule.officialTitle
"A Phase 3, 22-week, Multi-center, Randomized Withdrawal Study of TD-9855 in Treating Symptomatic Neurogenic Orthostatic Hypotension in Subjects With Primary Autonomic Failure"- protocolSection.statusModule.overallStatus
"TERMINATED"- protocolSection.designModule.phases
["PHASE3"]- protocolSection.statusModule.resultsFirstPostDateStruct.date
"2023-01-20"
Study condition terms
Intervention details are not present in the imported fields for this record. No drug-condition relationship is inferred from co-listing.
This index keeps the source fields it imported; it may not contain the complete original record. Verify wording and context in the linked source.